This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details.This website uses cookies, learn more
Posted on July 5, 2024 by Stefanie Seltmann
We are pleased to announce the publication of a new article here that presents the findings of a study investigating the perceptions and experiences of Australian researchers with regard to stem cell registration.
Australia contributes a notable number of cell lines to the Human Pluripotent
Posted on July 5, 2024 by Stefanie Seltmann
We have the following posters:
Wed, July 10 @ 5:45 pm: The Challenges of Tracking the Progress of hPSC-based Cell Therapies (Poster 213)
Thurs, July 11 @ 4:45 pm: Dynamic Governance: A New Era for Consent for Stem Cell Research (Poster 298)
Friday, July 12 @ 4:45 pm: The
Posted on May 30, 2024 by Stefanie Seltmann
We are pleased to announce the publication of a new article, entitled "A Standardized Nomenclature Design for Systematic Referencing and
Identification of Animal Cellular Material". This paper introduces the first standardized, human-readable nomenclature system that ensures the
generation of uniq
Posted on May 17, 2024 by Stefanie Seltmann
A new online resource has launched, offering information on the potential uses of human pluripotent stem cells and related ethical and societal issues. The site provides tailored fact sheets for key stakeholders, including:
Donors
Ethics Committees
Industry
Rese
Posted on May 6, 2024 by Stefanie Seltmann
We are delighted to share highlights from the recent Cell Lines in the 21st Century Symposium, where Andreas Kurtz delivered an engaging presentation on 'hPSCreg: the human pluripotent stem cell registry'. This symposium, hosted by Cellosaurus, aimed to address the critical issue of cell line miside
Posted on March 14, 2023 by Stefanie Seltmann
The Alzheimer’s disease collection (CW13) has been registered in hPSCreg®, consisting of 22 iPSC lines generated from
late-onset Alzheimer’s disease patients (female:15) and 44 controls (female:37). These iPSC lines, funded and owned by the
California Institute for Regenerative Med
Posted on January 10, 2023 by Stefanie Seltmann
The hPSCreg clinical study database is now listed on the WHO "s International Clinical Trials Registry Platform (ICTRP) as an External Search Platform!
https://www.who.int/clinical-trials-registry-platform/the-ictrp-search-portal/external-search-platforms
hPSCreg is a knowledgebase about human p
Posted on October 13, 2022 by Stefanie Seltmann
Over 100 clinical studies using hPSC-derived cells can now be found at hPSCreg®!
Have a look at the 100th study:
A Study To Evaluate Safety, Engraftment, And Efficacy Of VC-01 In Subjects With T1 Diabetes Mellitus (VC01-103)
Or check out the hPSCreg®
clinical studies database
Posted on June 16, 2022 by Stefanie Seltmann
Whether you’re joining us in person in San Francisco or logging on virtually, be sure to connect with us from June 15 - 18. You can find us at the poster session with poster #206 and #207
Posted on May 9, 2022 by Stefanie Seltmann
We are happy to present our new publication
about the Human pluripotent stem cell registry.
This publication describes the current status of hPSCreg and it's mission. An outlook is provided on the establishment of digital
representatives of donors using hybrids of data and hPSC-based biological
Posted on October 28, 2021 by Stefanie Seltmann
Have a look at the new video from the EBiSC project.
This ISSCR's focus session details how EBiSC2 partners are adapting and consolidating iPSC expansion, differentiation and cryopreservation approaches to help ease transition into high volume applications whilst also ensuring accessibility for n
Posted on July 21, 2020 by Stefanie Seltmann
We are happy to present our new publication
about the clinical study database in hPSCreg.
This publicly accessible database on the hPScreg platform provides a steadily updated comprehensive overview on hPSC-based clinical studies performed worldwide. The database can be found on our webpage ( cl
Posted on July 21, 2020 by Stefanie Seltmann
A new publication
on hPSCreg has been published in Stem Cell Research.
In this publication, we present a short primer on the
history of stem cell-based products, summarize the ethical and regulatory issues introduced in the course of working with
hPSC-derived products and their associated data,
Posted on January 15, 2020 by Stefanie Seltmann
We are pleased that hPSCreg is now entered as a recognized resource in the
International Rare Diseases Research Consortium (
IRDiRC ).
Patient-derived hiPSC lines are valuable source reagents for producing specific
cell types for use in individualized disease modeling and drug testing, especiall
Posted on December 4, 2019 by Stefanie Seltmann
We are pleased that the International Stem Cell Banking Initiative (ISCBI) has published a call for the implementation of the standard
pluripotent stem cell (hPSC) nomenclature. The ISCBI strongly recommends the registration of
hPSC - standard names in hPSCreg .
More details can be found here
Posted on October 2, 2019 by Stefanie Seltmann
The
1st Advanced Therapies Science Meeting from Restore will take place at 25. and
26. November 2019 in Berlin. Dr. Andreas Kurtz from hPSCreg will talk
about "Ethics management" and "Stem cell data standards".
We hope to meet you at the meeting and look forward to fruitful discussions.
Posted on August 23, 2019 by Stefanie Seltmann
We are happy that our new publication "A pathway for attesting ethical provenance of cell lines:
Lessons from the European human pluripotent stem cell registry (hPSCreg)" has been released.
You can find the publication here
Posted on July 23, 2019 by Stefanie Seltmann
The European Bank of induced pluripotent Stem Cells EBiSC is looking for your input
as international iPSC scientists.
The user survey to gather feedback on your requirements from an iPSC repository is now
available .
This includes assessing provision of:
Specific disease variant iPSCs
Posted on March 28, 2019 by Stefanie Seltmann
Due to the great progress in the field of research on pluripotent stem cell lines and their application in the clinical area, hPSCreg now also offers an overview of studies and the associated cell lines.
The overview is publicly available here.
Registered users also have the option of registering
Posted on March 13, 2019 by Johannes Dewender
EBiSC2 will secure long-term access to well characterised and quality-controlled hiPSCs for academic and commercial researchers worldwide, continuing to support R&D activities such as disease modelling and drug discovery.
Brussels, 11th March 2019 (12:00 CET)
EBiSC2 builds on the achievements of t
Posted on July 30, 2018 by Stefanie Seltmann
We want to highlight a new publication: Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials
The human pluripotent stem cell (hPSC) research landscape is rapidly evolving. To assess possible novel trend
Posted on May 25, 2018 by Stefanie Seltmann
We have updated our Terms of Use and Privacy Policy to make it easy for the hPSCreg user to understand what information we have about them, what we do with it, and why.
While we believe this updated policy will serve all of our users better, we are making these changes to make sure that we are compl
Posted on March 6, 2018 by Robert Müller
Registered hPSCreg users can now publicly share feedback, experiences or results with the research community for each cell line. When logged in, you can provide comments directly within the cell line details page in the „General“ section.
Posted on January 11, 2018 by Stefanie Seltmann
Unambiguous cell line authentication is essential to avoid loss of association between data and cells. The risk for loss of references increases with the rapidity that new human pluripotent stem cell (hPSC) lines are generated, exchanged, and implemented. Ideally, a single name should be used as a g
Posted on September 19, 2017 by Stefanie Seltmann
hPSCreg now provides an automatic, pre-filled word template to publish your cell line in Stem Cell Research - Lab Resources. The template can be downloaded after the cell line has been submitted. For further details click here.
Posted on February 28, 2017 by Johannes Dewender
We have a new public API to list all hPSCreg cell line names and to find the hPSCreg name for a cell line. See the documentation for details.
Posted on August 31, 2015 by Stefanie Seltmann
The Human Pluripotent Stem Cell Registry has entered an agreement to publish the description of cell lines registered with hPSCreg under the article type “Lab Resource: Stem Cell Line” in the journal Stem Cell Research.
Scientists registering their PSC lines in hPSCreg will have the opportuni
Posted on June 24, 2015 by Weiping Zhang
BioSpace.com features a press release about the Human Pluripotent Stem Cell Registry hPSCreg;
"A global registry has been enhanced and expanded to offer more in-depth information and analysis on human pluripotent stem cell lines, including human embryonic (hESC) and adult derived induced pluripot
Posted on February 18, 2015 by Fritz Lekschas
World map of ES and iPS cell lines is now online. Currently the map shows the (log) number of registered ES and iPS cell lines as well as the legal status for ES cell line research in a heat map fashion.
To open the world map click on it or visit hescreg.eu/map.
Posted on November 4, 2014 by Robert Müller
The hESCreg portal was publicly relaunched on November 4 at the German Stem Cell Network's (GSCN) annual conference in Heidelberg. The re-launch adds new and expanded functionality to the portal, including an online registration tool for human embryonic and induced pluripotent cell lines and the aut
Posted on June 26, 2014 by Robert Müller
MADISON, Wis., and HERTFORDSHIRE, England ‐ The UK Stem Cell Bank (UKSCB) and WiCell announce a revolutionary and world‐leading initiative to exchange cell lines so a combined panel of each institution’s most popular cell lines will be available through each center. The plan will ease deliver
Posted on June 11, 2014 by Robert Müller
The first ever clinical trial using human embryonic stem cell – derived oligodendrocytes has received new funding, after it was abandoned by Geron in 2011 (Nature 479, 459; 2011). The 14.3 million US$ provided by CIRM to Asterias Biotherapeutics of Menlo Park, California will be used to treat and
Posted on June 3, 2014 by Robert Müller
A public hearing on a petition to stop funding of research with human embryonic stem cells (One of us) took place in Brussels on April 9, 2014. The European Commission has released its response and decision on the citizen’s initiative and firmly supports its current policy for funding such researc
Posted on June 3, 2014 by Robert Müller
Three recent papers have successfully reprogrammed human adult somatic cells by somatic cell nuclear transfer (SCNT) into oocytes (de Souza, 2014). While the first successful human pluripotent NT-line were derived from fetal dermal fibroblasts and dermal fibroblasts from a patient with Leigh syndro
Posted on June 3, 2014 by Robert Müller
The Japanese government has implemented a novel regulatory framework for stem cell based therapies: The Act on the Safety of Regenerative Medicine and the Revised Pharmaceutical Affairs Law. Recognizing that the conventional regulatory framework for pharmaceuticals is unsuitable for cell based regen
Posted on April 25, 2014 by Hermann Azong
The UKSCB technical forums are run to provide a platform for bench scientists
to exchange views and discuss topics relevant to their areas of work. They act
as a place to network and facilitate informal discussion which will be of value to
the individual scientist and promote best practice in
Posted on March 26, 2014 by Hermann Azong
A consortium of 26 partners has been formed to establish the “European Bank for induced pluripotent Stem Cells” (EBiSC) with support from the IMI. The EBISC iPS cell bank will act as a central storage and distribution facility for human iPS cells, to be used by researchers across academi
